Please login to the form below
First Cymbalta generics approved in the US
Lilly prepares for onslaught of competition for antidepressant
GSK invests £200m in UK medicine manufacturing
Will upgrade two sites and build centre for manufacturing innovation
G8 sets 2025 target for effective dementia treatment
World leaders pledge more research funding
Merck takes Alzheimer's hope into phase III
MK-8931 moves to late-stage study after positive early data
Publicis Groupe spending spree continues
Marketing firm buys US-based healthcare analytics firm Verilogue
Police to probe Novo Nordisk over disclosure delay
Regulator says pharma company was late to announce FDA decision to not approve Tresiba and Ryzodeg
EC fines J&J and Novartis in pay-for-delay case
Says companies delayed entry of generic painkiller
IMI launches dementia trials alliance
EU group wants to revamp approach to Alzheimer’s research
FDA panel backs Takeda's inflammatory bowel disease drug
Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis
Digital blooms: multichannel marketing in China
The evolution of marketing and its increasing use of new channels is as relevant to China as it is to mature pharma markets
-
This month in 1901: The first Nobel Prize awardsSerum therapy work took inaugural medicine award
-
Smart Glasses: A new look for healthcare?Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Sanofi's Aubagio backed by NICEOral MS drug recommended for NHS use in England and Wales
-
Novartis' Tasigna tops Glivec in long-term trialBoost ahead of patent expiry for leukaemia drug
-
AZ donates Brixham lab to Plymouth UniversityWill create global research and education facility
-
Study highlights poor diabetes consultationLess than a third of patients asked for input into their treatment plans
-
AZ wins EU approval for four-strain flu vaccineFluenz Tetra offers competition to GSK’s Influsplit Tetra/Fluarix Tetra
-
Auxilium's Xiaflex cleared in US for erection disorderFDA approval to treat Peyronie's disease
-
Novartis myeloma drug clears phase III trialPanobinostat on course to be first in new class of treatment for bone marrow cancer
Latest appointments
-
Senior hire for 3D CommunicationsAllison May Rosen joins as communications lead for FDA Advisory Committee projects
-
ABPI names NHS partnership managerRaj Tugnet will lead work to strengthen pharma/NHS collaboration in UK
-
Senior hires at Precision Health MediaNew VP for ad sales, chief financial officer ad member of the board
-
Ketchum loses healthcare headAmanda Sefton leaves to pursue “passion project” in wine trade
-
MSD appoints new UK headMike Nally moves from Swedish division
Featured jobs
- Global Brand Manager
- flexible salary + bonus + car allowance + benefits
- Brand Director - Highly Specialised Product - Global remit
- Highly Competitive Basic, Bonus + Benefits
- Commercial Manager
- Negotiable
- Regulatory Affairs Senior Manager, CMC - 12 month cotnract
- Competitive
Subscribe to our email news alerts
PMHub
Solaris Health
Medical communications beyond expectations We combine strategic and scientific acumen, experience and creativity.We will listen carefully to you and select...
Latest intelligence
- Doctors’ disease knowledge: an insight into Latin America
- A lack of specialists outside major cities means many major illnesses go undiagnosed...
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
Quick links
